Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EZH2 | Q15910 | 5/20 | 1.00 |
| ▸ | EZH1 | Q92800 | 2/20 | 0.73 |
| ▸ | EED | O75530 | 1/20 | 0.73 |
| ▸ | RBBP4 | Q09028 | 1/20 | 0.73 |
| ▸ | SUZ12 | Q15022 | 1/20 | 0.73 |
| ▸ | RBBP7 | Q16576 | 1/20 | 0.73 |
| ▸ | AEBP2 | Q6ZN18 | 1/20 | 0.73 |
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.73 |
| ▸ | HDAC1 | Q13547 | 11/20 | 0.72 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.66 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.66 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.66 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.66 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.66 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21271666 | 1.00 | EZH2 (1.00) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL31061547 | 1.00 | EZH2 (1.00) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL21271681 | 0.97 | EZH2 (0.93) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL30122881 | 0.97 | EZH2 (0.93) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL30123033 | 0.94 | EZH2 (0.89) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL21271670 | 0.94 | EZH2 (0.89) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL21271679 | 0.93 | EZH2 (0.87) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL28995994 | 0.93 | EZH2 (0.87) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL30122737 | 0.93 | EZH2 (0.87) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL21271631 | 0.93 | EZH2 (0.87) | EZH2EZH1EEDRBBP4SUZ12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025121807-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING EZH2 INHIBITOR AND METTL3 INHIBITOR | 인제대학교 산학협력단 | 2025-06-12 | — | — | WO | claimed |
| WO-2025121805-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING EZH2 INHIBITOR AND JAK3 INHIBITOR | 인제대학교 산학협력단 | 2025-06-12 | — | — | WO | claimed |
| US-20250144056-A1 | ANTIMICROBIAL HOST DEFENSE PEPTIDE-INDUCING COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECH COLLEGES (US) | 2025-05-08 | — | — | US | claimed |
| WO-2025059442-A1 | MODULATING PLANT RESPONSES TO STRESS AND GROWTH WITH CHEMICALS | REMOTE EPIGENETICS INC. (US) | 2025-03-20 | — | — | WO | claimed |
| US-20240408081-A1 | NOVEL SYNERGISTIC COMBINATIONS AND METHODS OF USE THEREOF FOR TREATING CANCERS | INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE - INSERM (FR) | 2024-12-12 | — | — | US | claimed |
| EP-4423254-A1 | COMPOSITIONS AND METHODS FOR PROMOTING IN VITRO MATURATION OF CELLS | Memorial Sloan Kettering Cancer Center (US) | 2024-09-04 | — | — | EP | claimed |
| US-20240279600-A1 | COMPOSITIONS AND METHODS FOR PROMOTING IN VITRO MATURATION OF CELLS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-08-22 | — | — | US | claimed |
| EP-4401719-A1 | NOVEL SYNERGISTIC COMBINATIONS AND METHODS OF USE THEREOF FOR TREATING CANCERS | UNIVERSITE DE BORDEAUX (FR) | 2024-07-24 | — | — | EP | claimed |
| WO-2023076554-A9 | COMPOSITIONS AND METHODS FOR PROMOTING IN VITRO MATURATION OF CELLS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-07-11 | — | — | WO | claimed |
| CN-117979962-A | Novel synergistic combinations for treating cancer and methods of use thereof | 波尔多大学 | 2024-05-03 | — | — | CN | claimed |
| CN-117503930-A | Application of PRC2 complex as target in developing medicine for preventing and treating neurodegenerative diseases or central nerve injury diseases | 北京干细胞与再生医学研究院 | 2024-02-06 | — | — | CN | claimed |
| CN-117100866-A | Antitumor angiogenesis medicine synergist, antitumor medicine composition and application | 兰州大学第二医院 | 2023-11-24 | — | — | CN | claimed |
| WO-2023147573-A2 | ANTIMICROBIAL HOST DEFENSE PEPTIDE-INDUCING COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGES (US) | 2023-08-03 | — | — | WO | claimed |
| CN-116510024-A | Composition, preparation method and application thereof | 上海复东生物医药有限责任公司 | 2023-08-01 | — | — | CN | claimed |
| WO-2023041674-A1 | NOVEL SYNERGISTIC COMBINATIONS AND METHODS OF USE THEREOF FOR TREATING CANCERS | Universite de Bordeaux (FR) | 2023-03-23 | — | — | WO | claimed |
| EP-4151208-A1 | NOVEL SYNERGISTIC COMBINATIONS AND METHODS OF USES THEREOF FOR TREATING CANCERS | UNIVERSITE DE BORDEAUX (FR) | 2023-03-22 | — | — | EP | claimed |
| EP-4728051-A1 | STANDARDISING PLURIPOTENT STEM CELLS | United Kingdom Research and Innovation (GB) | 2026-04-22 | — | — | EP | disclosed |
| EP-4608876-A2 | ENDOCYTIC AGENTS | BioVentures, LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| CN-113461678-B | Tubulin degrading agents CRSMs and uses thereof | 四川大学 | 2022-09-06 | — | — | CN | disclosed |
| WO-2022094477-A1 | METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2022-05-05 | — | — | WO | disclosed |